Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States

INTRODUCTION: The National Health and Nutrition Examination Surveys show that many people with type 2 diabetes (T2D) in the USA fail to achieve recommended treatment targets. In the SUSTAIN 7 randomized controlled trial, once-weekly semaglutide (0.5 and 1.0 mg) was superior to comparative doses of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkinson, Lars, Hunt, Barnaby, Johansen, Pierre, Iyer, Neeraj N., Dang-Tan, Tam, Pollock, Richard F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984908/
https://www.ncbi.nlm.nih.gov/pubmed/29557057
http://dx.doi.org/10.1007/s13300-018-0402-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984908/
https://www.ncbi.nlm.nih.gov/pubmed/29557057
http://dx.doi.org/10.1007/s13300-018-0402-8

Ejemplares similares